DENTSPLY SIRONA’s (XRAY) Buy Rating Reiterated at Needham & Company LLC

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “buy” rating reaffirmed by Needham & Company LLC in a report released on Tuesday,Benzinga reports. They currently have a $25.00 price objective on the medical instruments supplier’s stock. Needham & Company LLC’s price objective suggests a potential upside of 36.09% from the company’s current price.

A number of other equities research analysts have also commented on XRAY. Mizuho initiated coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target on the stock. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Finally, Barrington Research lowered their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Nine analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $26.33.

DENTSPLY SIRONA Price Performance

XRAY opened at $18.37 on Tuesday. The stock has a market cap of $3.65 billion, a P/E ratio of -8.87, a P/E/G ratio of 1.83 and a beta of 0.96. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $34.91. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a fifty day simple moving average of $19.04 and a 200 day simple moving average of $22.04.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently made changes to their positions in the company. State of Alaska Department of Revenue lifted its stake in DENTSPLY SIRONA by 2.4% in the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock valued at $637,000 after acquiring an additional 560 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after purchasing an additional 564 shares during the period. MML Investors Services LLC raised its holdings in shares of DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 620 shares during the period. Allworth Financial LP lifted its stake in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares during the last quarter. Finally, Blue Trust Inc. grew its holdings in DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after purchasing an additional 707 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.